Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity. Biogen's newer products ...

Samsung Bioepis, Biogen receive positive CHMP opinion for aflibercept biosimilar, Opuviz: Incheon, Korea Monday, September 23, 2024, 12:00 Hrs [IST] Samsung Bioepis Co., Ltd., a b ...

The patents cover sales of Biogen products for MS that are covered by a Forward Pharma patent and have dimethyl fumarate as an active pharmaceutical ingredient. The two companies say they intend ...

Biogen hopes Leqembi and other new products will drive growth as it reduces costs and grapples with plunging demand for its multiple sclerosis therapies, some of which face competition from ...

The patents cover sales of Biogen products for MS that are covered by a Forward Pharma patent and have dimethyl fumarate as an active pharmaceutical ingredient. While the protection of Tecfidera ...

OPUVIZ™, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen’s second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

OPUVIZ, a biosimilar referencing Eylea1 (aflibercept), is Samsung Bioepis and Biogen's second ophthalmology biosimilar to be recommended for marketing authorization by the European Medicines Agency IN ...

Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine ...

Viehbacher, Biogen President and Chief Executive Officer ... our dependence on sales from our products; uncertainty of long-term success in developing, licensing, or acquiring other product ...

Dr. Lloyd Minor and Prof Sir Menelas Pangalos bring significant scientific expertise and considerable experience in medicine research and developmentCAMBRIDGE, Mass., Sept. 12, 2024Inc. (Nasdaq: BIIB) ...

Friedreich's ataxia is a rare, debilitating and life-shortening neuromuscular disease caused by genetic factors 1 If approved ...